In spite of the global efforts of the World Health Organization (WHO) and partners to reduce the incidence of tuberculosis (about 2% per year) and its mortality (about 3% per year), the disease is still a global killer and has primary public health importance, with an estimate of 10.4 million cases in 2016. (1) The End TB Strategy and its vision (zero tuberculosisrelated deaths, cases, and suffering) underlies the possibility to eliminate tuberculosis as a public health priority in countries with a low incidence of tuberculosis. (2) (3) (4) Pillar 2 of the End TB Strategy clearly emphasizes the importance of collaboration at different levels. This international collaboration represents the last of the eight core areas to pursue tuberculosis elimination. (4) Translating that into simple words, international collaboration comprises all of the interactions involving clinicians, laboratory staff, public health offi cers, national tuberculosis programs, other programs (HIV/AIDS programs and diabetes programs in some countries), Ministries of Health (as well as Ministries of Justice for jails/prisons, Ministries of Interior for the migration-related issues, Ministries of Transportation, etc), private sector, pharmaceutical sector, civil society, representatives of the affected communities, and international organizations, among others. (4, 5) As of today, several TB Networks exist: the Stop TB Partnership (6) has a long tradition in supporting advocacy. In addition, one of the best examples is the Brazilian Rede TB, which shows that the best research efforts, even in a large country as is Brazil, can collaborate to solve country-specifi c priorities and involve national tuberculosis programs and authorities in the plan. (7) (8) (9) (10) (11) However, as of today, no global tuberculosis network is operational enough to put together all of the abovementioned actors in order to support the fi ght against tuberculosis.
To respond to this need, the Global TB Network* (GTN) will be launched at the second Conference of the World Association for Infectious Diseases and Immunological Disorders (WAidid), (12) which will take place in the city of Milan, Italy, from October 18-20 of 2018, involving an international group of experts and covering a wide range of perspectives.
The goal of the GTN is to pursue tuberculosis elimination with a global effort proactively, building on existing collaborations in the area of research, advocacy, and training. Its core objectives are to foster and conduct research on key unmet therapeutic and diagnostic needs in the fi eld of tuberculosis elimination, leveraging on multidisciplinary, multisectoral approaches and supportive interventions (i.e., training and advocacy activities) within the framework of the WHO End TB Strategy. Preliminary plans propose to focus on latent tuberculosis infection, multidrug-and extensively drug-resistant tuberculosis rapid diagnosis, and other neglected areas (pediatric tuberculosis, extrapulmonary tuberculosis, rehabilitation of tuberculosis sequelae, infection control, etc.)
The GTN represents the structured evolution of pre-existing global tuberculosis networks, including the international linezolid, carbapenems and bedaquiline study groups and the International Severe Cases and Rehabilitation Study Group, which produced over 40 articles in the last fi ve years in impact-factor, peer-reviewed journals, as well as various series on tuberculosis in different journals in collaboration with scientifi c societies, such as the European Respiratory Society, Sociedade Brasileira de Pneumologia e Tisiologia, and the Asociación Latinoamericana del Tórax. (13) (14) (15) (16) (17) (18) This new global network aims at collaborating with existing organizations, associations, institutions, and partners that are committed to fi ght against tuberculosis by complementing and boosting (and not duplicating) the existing initiatives.
The GTN is hosted by WAidid, (12) founded in July of 2014 in order to advance the scientifi c research in the fi eld of infectious diseases and immunology and to disseminate information on the related pathologies. WAidid is the response to the previous lack of a network that links associations and scientifi c societies focused on infections, vaccines, and immunology. WAidid, whose membership is free of charge, represents the bridge for a global multidisciplinary approach to infections (including tuberculosis) operating across all age groups.
The GTN is composed of three pillars: 
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